Sanovas, Inc.: A Savant in Pulmonary Procedures

The World Health Organization report, entitled “World Health Statistics 2011,” estimated that in 2008 over 154 million disability-adjusted life-years (DALY) were lost to respiratory diseases worldwide, with lung cancer alone attributing to thirteen million lives lost. “The science of interventional pulmonology is at its incipient stage. There remain limited options for diagnostic and treatment solutions for lung diseases,” points out Larry Gerrans, President, CEO and Founder of Sanovas, a company making the effort to meet the unmet needs for pulmonologists and Lung patients. Originally conceived to facilitate targeted drug delivery directly to solitary pulmonary nodules, Gerrans soon discovered the elephant in the room: “There were no effective tools to even get to the periphery of the lung. In fact, the tools that did exist were borrowed from other surgical specialties,” says Gerrans.

Gerrans’s inspiration to create the next generation of minimally invasive tools and technologies that could diagnose, treat and cure lung cancer was born. Sanovas has since re-invented surgical imaging, catheter science, physiologic measurement systems, diagnostic and treatment solutions that address the unmet needs for lung treatment. The company has built an enormous portfolio of patents and products and is delivering on its mission to provide Doctors a ubiquitous set of integrated tools that can diagnose and treat the lungs. Conjointly, the Sanovas team, consisting of medical device veterans, has contributed substantially to the science of surgery with a whole slew of innovations that have raised the bar for medical intervention today.

Making seismic changes in the field of advanced bronchoscopic imaging and minimally invasive surgery in general, is Sanovas’ surgical camera, dubbed MicroCam.